Radiotherapy for laryngeal cancers
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology
Reference25 articles.
1. [Hypopharynx and larynx cancers: propositions for the selection and the delineation of peritumoral microscopic disease volumes (lymph nodes excluded)];Lapeyre;Cancer Radiother,2010
2. Long-term results of a multicenter randomized phase III trial of induction chemotherapy with cisplatin, 5-fluorouracil, ±docetaxel for larynx preservation;Janoray;J Natl Cancer Inst,2016
3. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer;Forastiere;J Clin Oncol,2013
4. Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial;Bourhis;Lancet Oncol,2012
5. Induction chemotherapy followed by cetuximab radiotherapy is not superior to concurrent chemoradiotherapy for head and neck carcinomas: results of the GORTEC 2007-02 phase III randomized trial;Geoffrois;J Clin Oncol,2018
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. “Antiresorptive therapy in combination with radiation results in enhanced risk for necrosis and associated complications”;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2024-08
2. Clinical Outcomes of Curative Intent Radiotherapy by Helical Tomotherapy for Laryngeal Squamous Cell Carcinoma: A Retrospective Analysis in a Tertiary Referral Center;World Journal of Oncology;2024-02
3. Assessment of residual geometrical errors of clinical target volumes and their impact on dose accumulation for head and neck radiotherapy;Radiotherapy and Oncology;2023-11
4. EKSTERNAL RADYOTERAPİ ALAN LARİNKS KANSERLİ HASTANIN KOLCABA’NIN KONFOR KURAMI’NA GÖRE EVDE BAKIMININ PLANLANMASI: OLGU SUNUMU;Gazi Sağlık Bilimleri Dergisi;2023-08-25
5. Metal–Organic Framework PCN-224 Integrated with Manganese Dioxide, Platinum Nanoparticles, and Glucose Oxidase for Enhanced Cancer Chemodynamic Therapy;ACS Applied Nano Materials;2023-05-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3